Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.85 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.85 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL59830 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL11554769 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL27350 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL11584070 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL11559655 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL25148109 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| Morpholine SCHEMBL8649532 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL7747664 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL111814 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL897208 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4601031-A1 | ANODE ACTIVE MATERIAL FOR SECONDARY BATTERIES AND SECONDARY BATTERY INCLUDING SAME | SK On Co., Ltd. (KR) | 2025-08-13 | — | — | EP | claimed |
| CN-120058693-A | Organic small molecule fluorescent probe for lithium ion detection, synthesis method and application | 晋中学院 | 2025-05-30 | — | — | CN | claimed |
| CN-119998961-A | Negative electrode active material for secondary battery and secondary battery comprising same | SK新能源株式会社 | 2025-05-13 | — | — | CN | claimed |
| CN-119486583-A | Memristor imitating biological synapse structure and preparation method thereof | 中国科学技术大学苏州高等研究院 | 2025-02-18 | — | — | CN | claimed |
| EP-4448105-A1 | HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE | VIR Biotechnology, Inc. (US) | 2024-10-23 | — | — | EP | claimed |
| WO-2024076012-A1 | ANODE ACTIVE MATERIAL FOR SECONDARY BATTERIES AND SECONDARY BATTERY INCLUDING SAME | 에스케이온 주식회사 | 2024-04-11 | — | — | WO | claimed |
| CN-117659668-A | Low-temperature heat-curable resin composition, anisotropic conductive film, and connection structure | 常州德创高新材料科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| WO-2023179234-A1 | STABILIZER-CONTAINING FUNGICIDAL COMPOSITION PREPARATION | 沈阳中化农药化工研发有限公司 | 2023-09-28 | — | — | WO | claimed |
| CN-116759632-A | Crown ether lithium salt compound and perovskite lithium battery thereof | 美能能源技术(苏州)有限公司 | 2023-09-15 | — | — | CN | claimed |
| WO-2023114428-A1 | HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE | Vir Biotechnology, Inc. (US) | 2023-06-22 | — | — | WO | claimed |
| US-20030144323-A1 | For treatment of disorders and conditions mediated by the histamine receptor; allergies, sleep disorders, dementia | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-07-31 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5702804-A | Recording sheets | XEROX CORPORATION (US) | 1997-12-30 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0079920-A1 | NEW AZA-CROWN-ETHERS AND THEIR USE. | BORREGAARD IND (NO) | 1983-06-01 | — | — | EP | claimed |
| WO-1982004253-A1 | NEW AZA-CROWN-ETHERS AND THEIR USE | DALE JOHANNES | 1982-12-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144323-A1 | For treatment of disorders and conditions mediated by the histamine receptor; allergies, sleep disorders, dementia | HRH3, HRH2, HRH4 | MEN1 2707/4885KMT2A 389/4885GAA 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.